Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Cytori Therapeutics, Inc. Receives FDA Approval To Resume ATHENA Trial Enrollment

October 23, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) has received notification from the FDA that Cytori has provided additional information sufficient to support continuation of enrollment in its ATHENA cardiovascular trials. The FDA has agreed that the submitted data and protocol amendments support the fact that there are no subject protection concerns that preclude continuation of…

Celgene Beats The Street Again On Earnings And Analysts Couldn???t Be Happier

October 23, 2014 – 5:00 am | Edit Post

OSI Systems, Inc. Reports First Quarter Fiscal 2015 Financial Results

October 23, 2014 – 5:00 am | Edit Post

OSI Systems, Inc. (NASDAQ: OSIS) today announced financial results for the quarter ended September 30, 2014. Deepak Chopra, OSI Systems Chairman and CEO, stated, We are pleased to report solid first quarter performance which delivered record-breaking revenue, earnings and free cash flow providing a strong start to our fiscal year. Led by our Security division, our non-GAAP earnings increased…

High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity Research, Cedars-Sinai Medical Center Reveals

October 23, 2014 – 5:00 am | Edit Post

High-Fat Meals Could Be More Harmful To Males Than Females, According To New Obesity ResearchLos Angeles – Oct. 16, 2014 Male and female brains are not equal when it comes to the biological response to a high-fat diet. Cedars-Sinai Diabetes and…

OSI Systems, Inc. Reports First Quarter Fiscal 2015 Financial Results

October 23, 2014 – 5:00 am | Edit Post

OSI Systems, Inc. (NASDAQ: OSIS) today announced financial results for the quarter ended September 30, 2014. Deepak Chopra, OSI Systems Chairman and CEO, stated, We are pleased to report solid first quarter performance which delivered record-breaking revenue, earnings and free cash flow providing a strong start to our fiscal year. Led by our Security division, our non-GAAP earnings increased…

A new chink in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

A new dent in HIV-1′s armor

October 22, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a slumbering dragon, HIV can lay dormant in a person’s cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

10-minute Ebola test announced

October 22, 2014 – 3:27 pm | Edit Post

San Diego’s Genalyte says test works on its commercially available platform.

Edico starts selling high-powered genome processor

October 22, 2014 – 3:00 pm | Edit Post

A super-fast genome processer is now on sale by San Diego’s Edico Genome.

J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola

October 22, 2014 – 2:39 pm | Edit Post

There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in…
[[Click headline to continue reading.]]